Abstract

Pandemic of novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections in China is now become global public health crisis. At present 87.64% of the world is infected by this deadly illness. The risk from this epidemic depends on the nature of the virus, including how well it transmits from person to person, and the complications resulting from this current illness. The novel coronavirus has killed thousands of people in China and other countries as well; its rate of mortality is increasing day by day. There is an urgent need to control the virus by developing vaccine or any other antiviral drugs to save the world from this deadly viral infection.

Highlights

  • During 8 December 2019, several cases of pneumonia of unknown etiology have been reported in Wuhan, Hubei province, China [1]

  • Severe Acute Respiratory Syndrome (SARS)-COV-2 name has been given by International Committee on Taxonomy of Viruses (ICTV) and disease is named Coronavirus disease 19 (COVID-19) by World Health Organization (WHO)

  • Updates from China, and other countries indicate that the disease associated with SARS-CoV-2 appears to be relatively more contagious and rapidly spreading as compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) CoVs [4] (Figure 1)

Read more

Summary

Introduction

During 8 December 2019, several cases of pneumonia of unknown etiology have been reported in Wuhan, Hubei province, China [1]. On 7 Jan 2020 a novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified by the Chinese Center for Disease Control and Prevention (CDC) from the throat swab sample of a patient, and was subsequently named 2019-nCoV by WHO [2]. The majority of SARS and MERS CoVs cases were associated with nosocomial transmission in hospitals [7], resulting at least in part from the use of aerosol generating procedures in patients with respiratory disease.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call